AURN001 not checked

Aurion Biotech

FollowEvery change as it happens, and a Monday email
Stage
in Japan
Next date
Phase 3 trial completes
Trials
2 active
3 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“AURN001 will be injected to the anterior chamber of the eye.”In the company’s words, NCT07368959 on ClinicalTrials.gov
Tested for
Corneal Edema (2 trials), Corneal Endothelial Dysfunction, Fuchs Endothelial Corneal Dysfunction, Pseudophakic Bullous Keratopathy (PBK)
Main trialPhase 3
“The purpose of this study is to assess the efficacy and safety of single injection dose of AURN001 compared with placebo in adult participants with corneal edema secondary to corneal endothelial dysfunction.”In the company’s words, NCT07368959 on ClinicalTrials.gov

Other drugs for Corneal Edema

All 3 drugs for Corneal Edema

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials3

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting Jun 2027 AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction
Phase 2Active, not recruiting Oct 2025 Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction
Phase 1/2Completed 25 Oct 2024 A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow AURN001

Following is part of Solo: you see every change to AURN001 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in